At the end of October, the biennial Harley Street Health District Conference was held on Wimpole Street.
Hosted by the Harley Street Health District, which is owned and managed by The Howard de Walden Estate, the conference brought together senior figures from private healthcare, the NHS and the health technology sector to discuss issues affecting the area and the wider healthcare landscape.
A recurring question throughout the day was how to move healthcare innovation beyond the development stage and into everyday clinical practice. While speakers highlighted the opportunities presented by collaboration and investment, there was also recognition that putting new ideas into practice remains a significant challenge.
Location, location, location
In the keynote speech, Sir Malcolm Grant, Senior Advisor and Former Founding Chair of NHS England, discussed why he believes the Harley Street cluster is so effective, pointing in particular to its ownership model.
Grant argued that innovation clusters need an owner willing to adjust lease terms and underwrite risk, citing Hale House as an example.
Opening in April 2025, Hale House is an application-only HealthTech innovation hub. Developed by The Howard de Walden Estate and operated in partnership with workspace provider Spacemade, the facility is designed as a collaborative environment for healthtech startups, medtech teams, clinicians, investors and healthcare pioneers.
This new initiative has attracted partnerships with organisations including UCLPartners, the NHS Innovation Accelerator and One HealthTech. These partnerships reflect the ambition to bring different parts of the healthcare innovation ecosystem together, although the longer-term impact of such initiatives will ultimately depend on the work and outcomes they produce.
In another talk, William Pressley, CEO of Harley Street Clinic, Princess Grace Hospital and HCA UK, also highlighted ownership as a contributing factor to the success of the district, crediting the estate with raising the calibre of occupiers.
The discussions raised an interesting question about how much a healthcare cluster's success depends on its physical and organisational infrastructure, rather than simply the expertise of the organisations based there.
Trends in private healthcare in 2026
Listening to the talks, two themes emerged repeatedly.
The first was the emphasis on “private and public”, not “private or public”.
Mark Kildea, Chief Executive at Howard de Walden Estate, called the idea of treating the two sectors as opposing forces “lazy”, pointing to consultants who work across both. “Many of the consultants who treat patients on Harley Street also train the next generation of clinicians and lead teams in the NHS.”
There was a clear argument throughout the day that the two sectors could work together as partners rather than adversaries, potentially bringing benefits to both. However, the practicalities of translating that collaboration into wider improvements in healthcare remain an important consideration.
The second theme was that innovation is easy, but adoption is hard.
The discussion around implementing innovation beyond research was particularly prominent. Steven Davies, CFO of Guy’s and St Thomas’ NHS Foundation Trust, explained that the NHS can often be too “risk-averse”, suggesting there is an opportunity for private healthcare to help develop health technologies that could eventually be used more widely.
He did, however, point to ambient voice technology as a notable exception, with the technology already being adopted across the NHS.
The advice from speakers on bringing innovation into everyday care was relatively consistent, with several emphasising the importance of clinical leadership, evidence and investment in staff.
Firstly, start with the people doing the work. Welbeck’s Dr Peter Harper said new services work best when they are led by passionate consultants, with the organisation's role being to listen and support them.
HCA’s Will Pressley reinforced this, saying that picking out good ideas from a “wall of noise” comes down to listening. He gave the example of the company's women's health centre, which began with a single consultant's pitch.
Speakers also urged teams to think about scale and evidence from day one. Houston Methodist’s Homer Quintana said organisations should involve the people who will eventually adopt a technology at the start, agreeing on the data and health economics needed to demonstrate its value.
Harper and Pressley both stressed the importance of publishing results, with Pressley arguing that nurses and clinical teams should also be encouraged to write up their work.
Finally, speakers emphasised the need to invest in staff. Re:Cognition Health, for example, runs its own academy to prepare teams for rapid change.
The underlying message was that developing a promising technology or service is only one part of the process. Demonstrating its effectiveness, securing clinical support and making it workable at scale are considerably more complex challenges. This is particularly relevant when considering how innovations developed in private healthcare settings might be adopted by the NHS, where different funding, procurement and operational requirements apply.
Innovation in action in Harley Street
With 40% of London’s private healthcare and 11% of the entire UK’s sitting in this one location, Harley Street has a significant concentration of healthcare providers. That creates potential opportunities for collaboration and innovation, although the concentration of organisations alone does not necessarily guarantee that new developments will translate into wider improvements in care.
The day's talks nevertheless provided several examples of innovations being developed in the district.
HCA Healthcare’s Sarah Cannon Research Institute is performing some first-in-human cancer trials, while HCA and UCH jointly deliver TIL therapy.
Welbeck, a day-case-only provider, has developed outpatient treatment for atrial fibrillation, with published outcomes.
Re:Cognition Health has also presented an early dementia pathway combining biomarkers and AI-driven assessments, with over 100 trials run.
Beyond direct medical results however, there is also innovation in healthcare processes. A speaker from Pharmacierge discussed the company's e-prescribing pharmacy. The company has moved into a 5,500 sq ft dispensary on Wimpole Street, featuring a 30-foot dispensing robot, billed as the largest of its kind in the Harley Street Medical Area.
These examples illustrate the range of activity taking place in the district, from clinical research and treatment approaches to the practical application of technology in healthcare operations. The extent to which these developments can be replicated or adopted more widely will be an important measure of their longer-term significance.
The built environment on Harley Street: the good, the bad, and the beautiful
Harley Street’s buildings are a big part of its appeal, but they also create practical challenges. At the conference, several operators described how they adapt modern medical facilities to work within historic buildings.
HCA’s William Pressley was frank about the trade-off. The district’s 150-year-old buildings are, he said, “the worst place in the world to do really complex cardiac care, but they’re also the best place to do really complex cardiac care.” His reasoning was that a frightened patient walking in is met with something impressive, which can be reassuring.
Dr Peter Harper of Welbeck explained why size and layout matter. Many Harley Street buildings began life as townhouses, so floorplates were small, while a day-case centre needs treatment rooms, endoscopy and imaging close together. Welbeck’s answer was to stack those functions on top of each other, and it now runs a facility of about 100,000 sqft with four MRI scanners.
Pharmacierge’s Ed Ungar also explained that the 18th-century buildings “aren’t the easiest to deal with”. However, the company's dispensary on Wimpole Street still manages to house a multi-arm robot that selects medications and sends them down spiralling chutes between floors.
Others have expanded into buildings room by room. Re:Cognition Health’s founder described starting with two floors on Queen Anne Street and spreading across several addresses, joking that the company “metastasised, rather than moved”.
The estate's central management of many properties can also help occupiers find buildings suited to their requirements. However, the experiences described by operators illustrate the compromises involved in adapting older properties for increasingly complex healthcare services. The district's historic character may be part of its appeal, but it also presents practical challenges that other, purpose-built healthcare facilities may not face.
Final thoughts
The Harley Street Health District Conference offered a snapshot of some of the opportunities and challenges facing private healthcare and the wider health sector.
There was palpable enthusiasm for collaboration between private providers and the NHS, as well as for the potential of new technologies and clinical approaches. But the recurring message was that innovation alone is not enough. Getting new ideas adopted requires evidence, investment, clinical support and organisations willing to take risks.
Harley Street's concentration of healthcare providers, research activity and supporting infrastructure gives it a distinctive position in this landscape. Whether that translates into a wider contribution to the future of UK healthcare will depend not just on the innovations being developed, but on how successfully they can be implemented beyond the district.